At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase II Study of Weekly Vinorelbine and Paclitaxel in Elderly Patients With Advanced Non-Small Cell Lung Cancer
In Brief
A Phase 2 clinical trial evaluating Paclitaxel, Quality-of-Life Assessment, and 2 other interventions for Recurrent Non-Small Cell Lung Carcinoma and Stage IV Non-Small Cell Lung Cancer. Completed, enrolled 20 participants across 5 sites.
Detailed Summary
This phase II trial studies the side effects and how well vinorelbine tartrate and paclitaxel works in treating older patients with non-small cell lung cancer that has spread to other placed in the body. Drugs used in chemotherapy, such as vinorelbine tartrate and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving combination chemotherapy may kill more tumor cells.
Study Details
Timeline
Interventions
Given IV
Ancillary studies
Ancillary studies
Given IV